Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

CORAL GABLES, Fla., March 28, 2024 -- Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel...

Related Keywords

Canada ,United States ,America ,Richardj Daly ,Lee Eaton ,Edward Lambert ,Health Canada ,Family Association ,Exchange Commission ,Catalyst Pharmaceuticals Inc ,Price Wooldridge ,Board Member ,Catalyst Pharmaceuticals ,North America ,Duchenne Muscular ,Fast Track ,Full Prescribing ,Safety Information ,Full Prescribing Information ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,